Makers Laboratories Ltd.
Snapshot View

219.65 -2.05 ▼-0.9%

27 July 2021, 04:00:00 P.M.
Volume: 17,708

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website
Financial Indicators
Market Cap 109.01 Cr.
Earnings per share (EPS) -3.29 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 35.25 Trailing Twelve Months Ending 2021-03
Book Value / Share 100.92 Trailing Twelve Months Ending 2021-03
Price to Book Value 2.20 Calculated using Price: 221.70
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.49 Cr. 4,916,980 Shares
FaceValue 10
Company Profile

Makers Laboratories was incorporated in 1985. The company is promoted and managed by Ipca Laboratories group. The company is engaged in manufacturing pharmaceutical formulations and drug intermediaries. The company’s plants are located in Palghar and Dombivli in Thane (Maharashtra). The company has a prominent presence in the therapeutic segment of antibiotics.

Makers Drugs & Food Products was amalgamated with the company with effect from April 1, 1993. In the year 2006 Makers Laboratories informed that Purnima Jain has been appointed as an additional director of the company and designated as the whole-time director with effect from October 30, 2006.

The registered office of the company is located at 54 D,Kandivli Industrial Estates, Kandivli west Mumbai, Maharashtra- 400067 .

Products

  • Tablets & Capsules
  • Liquids (Oral)
  • Injectables
  • Drugs (Intermediates)
  • Creams & Ointments

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-0.92%
1 Week
+10.68%
1 Month
+15.73%
3 Month
-11.72%
6 Month
-17.13%
1 Year
+216.04%
2 Year
+427.37%
5 Year
+194.24%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -2.84 11.58 2.63 9.90 9.05 12.25 8.62 6.24 -0.29
Return on Capital Employed (%) 2.07 16.17 6.49 15.04 14.86 18.09 12.48 7.59 1.84
Return on Assets (%) -1.50 6.35 1.49 5.87 5.82 8.18 5.91 4.32 -0.18

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 20 22 23 25 26 34 37 42 45
Non Curr. Liab. 2 2 5 5 4 1 1 7 10
Curr. Liab. 16 14 13 10 9 15 16 11 19
Minority Int.
Equity & Liab. 38 39 41 39 40 50 53 60 74
Non Curr. Assets 19 17 17 17 18 25 26 37 50
Curr. Assets 19 21 24 22 23 25 28 23 24
Misc. Exp. not W/O
Total Assets 38 39 41 39 40 50 53 60 74

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 62 62 68 65 61 58 56 47 51
Other Income 1 2 1 0 1 1 2 3 0
Total Income 63 63 69 65 62 59 58 49 52
Total Expenditure -61 -58 -66 -61 -57 -53 -52 -44 -49
PBIDT 2 5 3 5 5 6 6 5 3
Interest -1 -1 0 0 0 0 0 0 -1
Depreciation -1 -1 -1 -2 -1 -1 -2 -2 -2
Taxation 0 -1 -1 -1 -1 -2 -1 -1 0
Exceptional Items 1 1
PAT -1 2 1 2 2 4 3 2 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 3 1 1 1 4 6 0 5 4
Cash Fr. Inv. -1 1 -1 -1 -1 -3 -2 -8 -8
Cash Fr. Finan. -2 -2 0 0 -1 0 -1 4 3
Net Change 0 0 0 0 1 3 -3 1 -1
Cash & Cash Eqvt 0 0 0 0 1 4 1 2 1

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 58.37 58.37 58.37 58.37 58.37 58.37 58.37 58.37 58.37
Public 41.63 41.63 41.63 41.63 41.63 41.63 41.63 41.63 41.63
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 22 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Notice to the shareholders of the Company in respect of Notice of 36th Annual General Meeting of the Company Annual Report for the financial year 2020-21 Remote E voting and Book Closure
Wed, 21 Jul 2021
The Register Of Member And Share Transfer Books Will Remain Closed From Friday 13Th August 2021 To Wednesday 18Th August 2021 (Both Days Inclusive) For<BR> Taking Record Of The Members Of The Company For The Purpose Of Annual General Meeting
The Register of Member and Share Transfer Books of the Company will remain closed from Friday 13th August 2021 to Wednesday 18th August 2021 (both days inclusive) for
taking record of the Members of the Company for the purpose of Annual General Meeting.
Wed, 21 Jul 2021
36Th Annual General Meeting (AGM) Of The Company Will Be<BR> Held On Wednesday 18Th August 2021 At 3.30 P.M. Through Video Conferencing / Other Audio Visual Means (VC/OAVM)
36th Annual General Meeting (AGM) of the Company will be
held on Wednesday 18th August 2021 at 3.30 p.m. through Video Conferencing / Other Audio Visual Means (VC/OAVM)

Technical Scans View Details

Mon, 26 Jul 2021
Strongly Underperforming Benchmark index Strongly Underperforming Benchmark index
Increasing Relative Strength - Benchmark index Increasing Relative Strength - Benchmark index
Strongly Underperforming Sectoral index Strongly Underperforming Sectoral index
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
Both SRS And ARS Below Zero Both SRS And ARS Below Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 168,769.22 688.00 -2.2%
Divi's Laboratories Ltd. 130,349.05 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. 90,021.63 4,844.35 -10.4%
Cipla Ltd. 76,675.40 913.20 -3.9%
Cadila Healthcare Ltd. 61,992.73 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. 58,965.37 4,078.80 -0.5%
Aurobindo Pharma Ltd. 55,837.02 905.70 -5.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 58.12 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 65.69 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.13 4,844.35 -10.4%
Cipla Ltd. Consolidated 2021-03 31.88 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 29.06 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 392.16 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.47 905.70 -5.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.63 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2021-03 14.02 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.14 4,844.35 -10.4%
Cipla Ltd. Consolidated 2021-03 4.18 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 4.77 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.83 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.55 905.70 -5.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 0.18 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 905.70 -5.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 10.09 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 905.70 -5.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 12.53 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 905.70 -5.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 17,131.99 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 905.70 -5.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 688.00 -2.2%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,796.80 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,844.35 -10.4%
Cipla Ltd. Consolidated 2020-03 1,546.98 913.20 -3.9%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 598.90 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,078.80 -0.5%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 905.70 -5.0%